Excellence in research is an important goal in the mission of the Division of Hematology. The division focuses on improving the diagnosis and treatment of hematologic diseases, including Waldenstrom macroglobulinemia.
Research related to Waldenstrom macroglobulinemia at Mayo Clinic includes drug trials, nonchemotherapy treatments and genetic links to the disease. Such research may lead to new treatments.
See a list of publications by Mayo Clinic authors on Waldenstrom macroglobulinemia on PubMed, a service of the National Library of Medicine.